Movement Alert｜GENSCRIPT BIO Rises 3.03% in Regular Trading, CXO Sector Momentum and Multiple Target Price Upgrades Fuel Buying

Market Focus

Yesterday

On August 26, GENSCRIPT BIO rose 3.03% in regular trading, trading at HK$35.84/share, with turnover of HK$456 million.

On the news front, the CXO sector continues to benefit from improving industry conditions as global biopharma investment and financing recovery accelerates innovative drug R&D spending, lifting sector stocks broadly. Following the company's interim results release, multiple institutions have intensified bullish coverage. JPMorgan raised its target price to HK$35, Huatai Securities assigned a target of HK$36.08, while BOCOM International and CICC both lifted targets above HK$32, maintaining buy ratings.

The company reported H1 revenue of US$404 million, up 27.3% year-over-year, with AIDD-related business achieving over 100% growth. Adjusted net profit surged 203.3% to US$62.5 million. The life sciences segment posted revenue of US$319 million with adjusted operating profit doubling to US$94 million, driven by AI-powered drug discovery demand, automation upgrades, and client expansion.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/news/1134013519"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1134013519\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1134013519?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134013519","market":"hk","top_or_hot":-1,"title":"Movement Alert｜GENSCRIPT BIO Rises 3.03% in Regular Trading, CXO Sector Momentum and Multiple Target Price Upgrades Fuel Buying","media":"Market Focus","content":"<p><p>On August 26, GENSCRIPT BIO rose 3.03% in regular trading, trading at HK$35.84/share, with turnover of HK$456 million.</p><p>On the news front, the CXO sector continues to benefit from improving industry conditions as global biopharma investment and financing recovery accelerates innovative drug R&D spending, lifting sector stocks broadly. Following the company's interim results release, multiple institutions have intensified bullish coverage. JPMorgan raised its target price to HK$35, Huatai Securities assigned a target of HK$36.08, while BOCOM International and CICC both lifted targets above HK$32, maintaining buy ratings.</p><p>The company reported H1 revenue of US$404 million, up 27.3% year-over-year, with AIDD-related business achieving over 100% growth. Adjusted net profit surged 203.3% to US$62.5 million. The life sciences segment posted revenue of US$319 million with adjusted operating profit doubling to US$94 million, driven by AI-powered drug discovery demand, automation upgrades, and client expansion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GENSCRIPT BIO Rises 3.03% in Regular Trading, CXO Sector Momentum and Multiple Target Price Upgrades Fuel Buying</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GENSCRIPT BIO Rises 3.03% in Regular Trading, CXO Sector Momentum and Multiple Target Price Upgrades Fuel Buying\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-26 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 26, GENSCRIPT BIO rose 3.03% in regular trading, trading at HK$35.84/share, with turnover of HK$456 million.</p><p>On the news front, the CXO sector continues to benefit from improving industry conditions as global biopharma investment and financing recovery accelerates innovative drug R&D spending, lifting sector stocks broadly. Following the company's interim results release, multiple institutions have intensified bullish coverage. JPMorgan raised its target price to HK$35, Huatai Securities assigned a target of HK$36.08, while BOCOM International and CICC both lifted targets above HK$32, maintaining buy ratings.</p><p>The company reported H1 revenue of US$404 million, up 27.3% year-over-year, with AIDD-related business achieving over 100% growth. Adjusted net profit surged 203.3% to US$62.5 million. The life sciences segment posted revenue of US$319 million with adjusted operating profit doubling to US$94 million, driven by AI-powered drug discovery demand, automation upgrades, and client expansion.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1134013519","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134013519","pubTimestamp":1787709316,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 26, GENSCRIPT BIO rose 3.03% in regular trading, trading at HK$35.84/share, with turnover of HK$456 million.On the news front, the CXO sector continues to benefit from improving industry...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"走势提醒|金斯瑞生物常规交易上涨3.03%，CXO板块势头和多次目标价上调推动买盘","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On August 26, GENSCRIPT BIO rose 3.03% in regular trading, trading at HK$35.84/share, with turnover of HK$456 million.On the news front, the CXO sector continues to benefit from improving industry conditions as global biopharma investment and financing recovery accelerates innovative drug R&D spending, lifting sector stocks broadly. Following the company's interim results release, multiple institutions have intensified bullish coverage. JPMorgan raised its target price to HK$35, Huatai Securities assigned a target of HK$36.08, while BOCOM International and CICC both lifted targets above HK$32, maintaining buy ratings.The company reported H1 revenue of US$404 million, up 27.3% year-over-year, with AIDD-related business achieving over 100% growth. Adjusted net profit surged 203.3% to US$62.5 million. The life sciences segment posted revenue of US$319 million with adjusted operating profit doubling to US$94 million, driven by AI-powered drug discovery demand, automation upgrades, and client expansion.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}